Dorsey Wright & Associates’s Takeda Pharmaceutical TAK Stock Holding History

Dorsey Wright & Associates’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.51M	Buy	+94,276	New	+$1.56M	0.26%	84

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Dorsey Wright & Associates's TAK Position: Q2 2026 in Review

Dorsey Wright & Associates opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 94,276 shares worth $1.51M. The stake represents 0.26% of the portfolio and ranks #84 among its holdings.

376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Dorsey Wright & Associates held 94,276 shares of Takeda Pharmaceutical worth $1.51M as of Q2 2026.
Takeda Pharmaceutical was a new Dorsey Wright & Associates position in Q2 2026.
Takeda Pharmaceutical made up 0.26% of Dorsey Wright & Associates's portfolio in Q2 2026, its #84 holding.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.